Form 4: 908 Devices Director Mark Spoto Reports Vesting and New Equity Grants

Mark Spoto, a Director at 908 Devices Inc., reported the settlement of previously vested Restricted Stock Units and the grant of new RSUs and stock options.

Summary

• On June 11, 2025, Mark Spoto, a Director of 908 Devices Inc. (MASS), settled 11,364 Restricted Stock Units (RSUs) into common stock upon their scheduled vesting.
• Following this transaction, Mr. Spoto directly holds 74,335 shares of common stock.
• Additionally, Mr. Spoto indirectly holds 3,599 shares of common stock through Razor's Edge Ventures, LLC, where he is a managing member, though he disclaims beneficial ownership except for his pecuniary interest.
• On June 12, 2025, Mr. Spoto was granted 14,083 new Restricted Stock Units (RSUs) at a price of $0.00, which are scheduled to vest on June 12, 2026, or prior to the 2026 Annual Meeting, subject to continued service.
• Also on June 12, 2025, Mr. Spoto was granted an option to purchase 6,516 shares of common stock at an exercise price of $7.19 per share, with vesting occurring in equal monthly installments over 12 months following June 12, 2025, and an expiration date of June 11, 2035.
• All reported transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The sentiment is positive as it reflects ongoing equity compensation for a director, aligning their interests with the company's long-term performance. The grants and vesting are routine and expected for a director, indicating stability in compensation practices.

Positives

• The settlement of 11,364 RSUs into common stock represents a realization of previously earned equity for the director.
• The grant of 14,083 new RSUs and options for 6,516 shares indicates continued alignment of the director's interests with shareholder value through future equity incentives.
• The new RSU grant has a vesting schedule that extends to June 2026, providing a future incentive for continued service and performance.
• The stock option grant provides a long-term incentive with an expiration date in 2035, encouraging sustained engagement and performance.

Future Outlook

The document primarily details past and future equity vesting and grant events for a director, rather than providing a forward-looking statement on the company's financial performance or strategic direction.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, common across all publicly traded companies. It reflects standard equity compensation practices for directors, aligning their interests with long-term company performance, which is a common trend in corporate governance across various industries.

Corporate Governance

Related Party Transactions

• Mark Spoto is a managing member of Razor's Edge Ventures, LLC, which directly owns 3,599 shares of 908 Devices Inc. common stock. Mr. Spoto disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Stakeholder Impact

• Shareholders: The issuance of new equity awards (RSUs and stock options) to a director can result in minor dilution, but it also serves to align the director's long-term interests with shareholder value creation.
• Employees: While this filing specifically concerns a director, the compensation structure may reflect broader company practices for incentivizing key personnel.

Next Steps

• The 14,083 new RSUs are scheduled to vest on June 12, 2026, or the day prior to the 2026 Annual Meeting of Stockholders, whichever occurs first.
• The 6,516 stock options will continue to vest in substantially equal monthly installments over the 12 months following June 12, 2025.

Key Dates

Keywords

SEC Form 4, Insider Trading, Restricted Stock Units, Stock Options, Equity Compensation, Director Compensation, 908 Devices Inc., MASS, Beneficial Ownership, Rule 10b5-1 Plan